Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

Last updated: October 18, 2021
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Effects Of Chemotherapy

Neuropathy

Neurologic Disorders

Treatment

N/A

Clinical Study ID

NCT03156595
PHRIP 2015 - HUS n°6395
  • Ages > 18
  • All Genders

Study Summary

Chimiotherapy produces neuropathies injuries to 30% to 70% cases. A third of those patients keeps suffering from this side effects disabilities and their quality of life is seriously affected.

Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them.

the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies.

The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Minimum age :18 years
  • Chemiotherapy- induced chronic neuropathies for at least 2 months with a DN4 score >4
  • Failure of classic treatment used to relief neuropathic
  • Having stopped chemotherapy treatment and being in complete or partial response or intumoral stability
  • Without any planed chemiotherapy during the study
  • Having signed a written informed consent.
  • French efficient understanding
  • With health insurance coverage
  • availability during all the study
  • With efficient contraception for women of childbearing age

Exclusion

Exclusion Criteria:

  • No participation to another study at the same time
  • Suffering from neuropathy before having chemotherapy
  • Other disease that may cause neuropathy
  • deafness
  • Any medicine that could cause neuropathy
  • Neurological or psychiatrical disease past or present
  • Mental retardation
  • Allergy to EMG's electrodes
  • Unable to consent, under tutelage or curatorship or judiciary safeguard
  • Pregnant or nursing woman

Study Design

Total Participants: 108
Study Start date:
August 04, 2017
Estimated Completion Date:
November 04, 2021

Connect with a study center

  • University Strasbourg Hospital

    Strabsourg, 67091
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.